Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Fermented Dairy-Rich Diet Could Thwart Heart Attacks

By Kenny Walter | October 31, 2018

Fermented dairy products may protect against heart attack, according to a new study from the University of Eastern Finland. Sour milk was the most commonly used low-fat fermented dairy product among study participants. Credit: Raija Törrönen

A diet filled with fermented dairy products like cheese, yogurt and kefir could help prevent coronary heart disease, according to a new study.

Researchers from the University of Eastern Finland have found that a very high consumption of non-fermented dairy products is associated with an increased risk of coronary heart disease, while fermented dairy products have more positive effects on blood lipid profiles and reduce the risk of heart disease.

“Here in Finland, people’s habits of consuming different dairy products have changed over the past decades,” Adjunct Professor Jyrki Virtanen from the University of Eastern Finland, said in a statement. “For instance, the consumption of milk and sour milk have declined, while many fermented dairy products, such as yoghurt, quark and cheeses, have gained in popularity.”

The University of Eastern Finland are currently conducting the Kuopio Ischaemic Heart Disease Risk Factor Study, an ongoing study exploring the associations of fermented and non-fermented dairy products with the risk of incident coronary heart disease.

The study includes approximately 2,000 men, who had their dietary habits assessed at the beginning of the study between 1984 and 1989 and then followed up on for an average of 20 years.

During the follow-up, 472 men were found to have an incident coronary heart disease event.

In the study, participants were divided into different groups based on how much of different dairy products they ate. The research team then compared the groups with the highest and lowest consumption while factoring various lifestyle and nutrition factors.

The participants were ultimately split into four different groups and based on their consumption of fermented dairy products with less than 3.5 percent fat, the risk of incident coronary heart disease was 26 percent lower in the highest consumption group compared to the lowest consumption group.

Sour milk was the most commonly used low-fat fermented dairy product. In addition, the consumption of high-fat fermented dairy products like cheese was not associated with the risk of incident coronary heart disease.

However, the researchers found that a very high consumption of non-fermented dairy products like milk was associated with an increased risk of incident coronary heart disease.

The study was published in the British Journal of Nutrition.    

Related Articles Read More >

Parallel Bio’s embraces in-house drug development as FDA backs animal testing alternatives
R&D 100 Winner Spotlight: A closer look at Thermo Fisher Scientific’s trio of R&D 100 wins in 2025
Life sciences M&A hit $240B in 2025 as Big Pharma preps for patent cliffs
Hansoh Bio signs 32,000-sq.-ft. lab lease at Research Square in Rockville, MD
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2025 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

R&D 100 Awards
Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE